# Clinical Trial Protocol: Alzheimer's Dementia Underlying Encephalopathy

> **NCT07222280** · NA · RECRUITING · sponsor: **Covenant Health, US** · enrollment: 30 (estimated)

## Conditions studied

- Alzheimer Dementia
- Alzheimer Disease
- Delirium Confusional State
- Encephalopathy
- Cognitive Abnormality

## Interventions

- **DIAGNOSTIC_TEST:** Quest AD-Detect blood test

## Key facts

- **NCT ID:** NCT07222280
- **Lead sponsor:** Covenant Health, US
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-10
- **Primary completion:** 2026-03-31
- **Final completion:** 2026-03-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07222280

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07222280, "Clinical Trial Protocol: Alzheimer's Dementia Underlying Encephalopathy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07222280. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*